2026 Dividends on Track: DBS, FCT and PLife Lead the Charge

After discussing the exuberant growth prospects of semiconductor plays like AEM (AWX) and UMS (55D) last week, it’s time to balance the scales with the grounded performance of my income counters.

Amidst the AGM season, DBS (D05), Frasers Centrepoint Trust (J69U), and Parkway Life REIT (C2PU) provided business updates for their latest quarters.

While each is navigating its own set of “nagging issues,” their overall robustness is more than satisfying.

But is it enough to move the needle on my dividends this year?

I’ll answer that at the end, but first, let’s start with my brief thoughts on the results.

DBS: Strong Wealth Management Growth Mitigated Decreasing NII

As expected, Net Interest Income (NII) continues to slide alongside a declining Net Interest Margin (NIM).

However, with SORA having more than halved compared to 1Q 2025, a mere 5% YOY drop in NII to S$3.494 billion speaks volumes about DBS’s success in growing its deposit base and executing its hedging strategies.

What impressed me even more was the 25% YoY surge in Wealth Management income to S$907 million—a major contributor to the record-high quarterly fee income.

If DBS continues to leverage its reputation as the “World’s Best Private Bank,” it should weather ongoing geopolitical uncertainties well.

This means it stands a good chance of maintaining its S$0.081 quarterly dividend even after the capital return exercise concludes in FY 2027.

FCT: Robust Performance All Round

Looking at the 1H 2026 highlights, there is very little to fault: near-full occupancy, improving tenant sales, positive rental reversions, and a decreasing average cost of debt.

This strong operational and financial showing led to a 1.4% YoY increase in DPU to S$0.06136.

While this was slightly lower than my expectation of a 2% increase, I’ll take it (not that I have any choice), especially given the ongoing and upcoming Asset Enhancement Initiatives (AEIs).

Notably, this DPU matches the high seen in 1H 2022, indicating that FCT has emerged from the high-interest-rate environment stronger than before.

Here are my key takeaways from the audio cast:

• GV Tiong Bahru Exit: The vacated space will be replaced by XVenture Park, an indoor active sports park originating in Chiang Mai. It’s a fresh concept that aligns with the move toward experiential retail.
  
• S$4.6 Million Retention: This amount was retained for working capital and AEIs, with a potential release in 2H 2026. This suggests my original 2-3% growth expectation wasn’t far off and could still be met by year-end.
  
• Cost of Debt: Guidance remains around 3.3% despite dropping to 3.2% this quarter. With only 66% of debt hedged to fixed rates (down from 81%), I suspect the cost of debt may trend lower as the cycle turns.

The “Nagging” Issue? The RTS Link

The impact of the Rapid Transit System (RTS) will likely weigh on market sentiment until FCT reports its first set of results after operations begin.

However, as I discussed in my previous post, I remain aligned with management’s view that the net impact will be muted.

Besides the continued strong occupancy at Causeway Point, CEO Richard Ng also shared that tenants are still renewing and locking in three-year leases.

FCT doesn’t provide the most exciting growth but its highly sought-after suburban retail space means a resilient and attractive yield of 5.2%.

PLife: New SG Hospital Rent Formula Lifts DPU By 15%

This was the business update I anticipated most.

With the completion of Project Renaissance and the new rent review formula kicking in, the DPU jumped 15.1% YOY to S$0.0442 (just a tad under my S$0.045 target).

What dampened the mood slightly was continued JPY FX pressure and an unexpected tenant exit from five Japanese nursing homes.

However, this actually highlights PLife’s resilience. Its JPY net income hedges (extending to 1Q 2029) and security deposits effectively mitigated these challenges.

As discussed previously, PLife rarely struggles to find operators in the mature Japanese nursing home market. Indeed, leasing discussions are already underway for those five repossessed Osaka properties, potentially on improved terms.

Note: I wasn’t able to attend the PLife AGM this year as it clashed with the UMS meeting. For those looking for coverage of the session, you can check out the sharing by dreamer1213 and Spinning_Top at InvestingNote.

1H 2026 Dividends: Boosted by 9.4%

The robust performance from DBS and FCT provided a welcome boost to my dividends this half, resulting in a pleasing 9.4% YOY increase.

However, due to my portfolio rebalancing over the past month, I expect full-year dividend growth to settle in the low single digits.

I have fully divested VICOM (WJP) and further trimmed OCBC (O39) to partially fund additions in UMS (558) and Venture (V03). While this created a temporary dividend “loss,” I don’t mind the trade-off.

My primary goal remains a total annual return of at least 6%, which can be derived from either dividends or capital gains.

Moreover, with some proceeds still to be deployed and other income counters yet to report, there is still a good chance to surpass the record dividends of S$30,100 achieved in 2025.

Related Post

DBS AGM 2026: My Takeaways and Why I’m Not Buying Yet

FCT Pre-AGM 2026: Will DPU Grow Meaningfully? (Plus RTS Analysis)

FCT AGM 2026: Why I’m Staying Vested (4 Key Takeaways)

Beyond DPU Jump: Potential 15% Return for Parkway Life REIT in 2026?